Physician profile

Arun Kumar Durgam

Internal Medicine · New York, NY

NPI 1619225422

$741.95

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$634.54

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $172.87 2022-2024 Xarelto
Inari Medical, INC. $156.76 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Vifor Pharma, INC. $124.97 2023 Korsuva, Veltassa
Mallinckrodt Hospital Products INC. $101.79 2024 Terlivaz
Medtronic, INC. $96.16 2024 Endo Gia Ultra
Astrazeneca Pharmaceuticals LP $47.91 2021
Novartis Pharmaceuticals Corporation $22.76 2021
Melinta Therapeutics, LLC $18.73 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Arun Kumar Durgam

$741.95

in general payments reported 2019-2025

Years
2021-2024
Top company
Janssen Pharmaceuticals, INC

https://glasscript.com/doctor/1293530/arun-kumar-durgam

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.